ScholarLens Back to search
2019•Journal of Thoracic OncologyOpen access

P1.01-104 Survivals in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer Treated with First-Line Crizotinib

Yun Gao, Chang Lu, Hui Chen, Zhihui Wang, Biao Wang, X. Zhang, Chong‐Rui Xu, Yi-Long Lung Cancer Wu, Jin‐Ji Yang

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Crizotinib, ROS1, Medicine, ALK inhibitor, Anaplastic lymphoma kinase, Oncology, Lung cancer, Chemotherapy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
P1.01-104 Survivals in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer Treated with First-Line Crizotinib — Research Paper | ScholarLens